Webinar: Matching ultra-rare cases in the clinic
Check out now the recording of the webinar that took place on June 3rd, 2022 about matching ultra-rare cases in Read more
Personalizing Medicine with Artificial Intelligence and Facial Analysis
Personalizing Medicine with Artificial Intelligence and Facial Analysis Presented by Omar Abdul-Rahman, MD, University of Nebraska Medical Center Precision Medicine Read more
The Genomics Collaborative: How to Design the Future of Health—Together
ThinkGenetic recently hosted a panel discussion among researchers involved in the Genomics Collaborative, an FDNA initiative connecting researchers, clinicians, Read more
AI in Healthcare: Separating the Hype from the Hope
FDNA’s CEO Dekel Gelbman recently spoke to hundreds of leaders during the Stanford Big Data in Precision Health Summit. The Read more
“Where are the limits?”
Big data, next-generation phenotyping, and the possibilities for precision medicine This post is based on a presentation given at the Read more
FDNA and Face2Gene Featured at ESHG
A flock of researchers from around the globe shared their findings in dysmorphology and molecular genetics at this year’s Read more
Dr. Christine Stanley: Face2Gene LABS at WuXi NextCODE: Phenotyping for Improved Variant Prioritization
Note: This talk was presented at the 2018 ACMG annual meeting. The video can be seen below, or at this link> Read more
Dr. John Carey: Delineating Genetic Syndromes and Next-Generation Phenotyping
Note: This talk was presented at the 2018 ACMG annual meeting. The video can be seen below, or at this Read more
Dr. Karen Gripp: Face2Gene RESEARCH for Deep Phenotyping of Novel Syndromes
Note: This talk was presented at the 2018 ACMG annual meeting. The video can be seen below, or at this Read more
FDNA’s Keynote at ePharma: Using Next-Generation Phenotyping For Precision Medicine Across the Pharma Value Chain
NOTE: This post is based on a presentation made at the March 2018 ePharma conference in New York City. Read more
Redefining Phenotyping for Clinical Advancements and Variant Prioritization
FDNA’s CEO, Dekel Gelbman, joined two distinguished members of the genetics community—Dr. John Carey (University of Utah) and Dr. Christine Read more